SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS ALECTINIB, COBIMETINIB, SATRALIZUMAB, VISMODEGIB, RISDIPLAM, OBINUTUZUMAB, EMICIZUMAB, TRASTUZUMAB SUBCUTÁNEO, TRASTUZUMAB EMTANSINA
1 fournisseur attributaire•27 lots attribués•28,35 M € attribués
Acheteur: Servicio Murciano de Salud / Espinardo, Spain
Valeur attribuée
28,35 M €
Valeur estimée
28,35 M €
Attribué à 100% de la valeur estimée
Date d'attribution
12 févr. 2024
Lauréats
1
Lots attribués
27
Valeurs d'attribution
Total de l'avis
28,35 M €
Somme des lots
55,47 M €
Le total de l'avis TED et les valeurs par lot ne correspondent pas exactement.
Lauréats
Madrid, ESP
28,1 M € Ce contrat
32 avis d’attribution•78 lots attribués•168,67 M € au total
Lots attribués
| Lot | Titre | Lauréat | Valeur | CPV principal |
|---|---|---|---|---|
| LOT-0025 | Non précisé | 15,6 M € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0022 | Non précisé | 7,9 M € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0015 | ROCHE FARMA, S.A | 7,4 M € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0016 | ROCHE FARMA, S.A | 4,4 M € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0026 | ROCHE FARMA, S.A | 3,0 M € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0023 | Non précisé | 2,7 M € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0011 | ROCHE FARMA, S.A | 2,5 M € | Medicinal products for the blood, blood-forming organs and the cardiovascular system (33620000) | |
| LOT-0012 | ROCHE FARMA, S.A | 1,6 M € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0013 | ROCHE FARMA, S.A | 1,4 M € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0003 | ROCHE FARMA, S.A | 1,3 M € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0001 | ROCHE FARMA, S.A | 980 241 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0008 | ROCHE FARMA, S.A | 915 270 € | Medicinal products for the blood, blood-forming organs and the cardiovascular system (33620000) | |
| LOT-0019 | Non précisé | 884 112 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0018 | ROCHE FARMA, S.A | 833 464 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0010 | ROCHE FARMA, S.A | 732 220 € | Medicinal products for the blood, blood-forming organs and the cardiovascular system (33620000) | |
| LOT-0014 | ROCHE FARMA, S.A | 624 371 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0005 | ROCHE FARMA, S.A | 606 492 € | Other nervous system medicinal products (33661700) | |
| LOT-0006 | ROCHE FARMA, S.A | 436 464 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0002 | ROCHE FARMA, S.A | 331 782 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0007 | ROCHE FARMA, S.A | 320 345 € | Medicinal products for the blood, blood-forming organs and the cardiovascular system (33620000) | |
| LOT-0020 | Non précisé | 272 995 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0017 | ROCHE FARMA, S.A | 259 000 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0004 | ROCHE FARMA, S.A | 206 546 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0024 | Non précisé | 118 477 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0009 | ROCHE FARMA, S.A | 91 527 € | Medicinal products for the blood, blood-forming organs and the cardiovascular system (33620000) | |
| LOT-0021 | ROCHE FARMA, S.A | 52 499 € | Antineoplastic and immunomodulating agents (33652000) | |
| LOT-0027 | ROCHE FARMA, S.A | — | Antineoplastic and immunomodulating agents (33652000) |